HLS Therapeutics Inc T.HLS

Alternate Symbol(s): HLTRF

HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Psychiatry and Vascepa. Its Clozaril is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. The Vascepa (icosapent ethyl capsules) is a single-molecule prescription product in use to reduce the risk of cardiovascular events.

TSX:HLS - Post by User

HLS Therapeutics Inc

Bullboard Posts

Comment by Aspertheoldmanon Mar 21, 2012 8:57pm

188 Views

Post# 19702988

RE: RE: Blair still selling

Scotia (Merchant Capital) did not report any sale for today nor yesterday, although they might be late in reporting

Blair did report himself the sale of 50,000 @ $2.10 and 20,000 at $2.14.

The report of TMX come from the brokers not from the insiders themselves. Stockbrkers may forget to check the insider box on their partial sale slips.

Bullboard Posts

Unique Battery Metals opportunity in Quebec